Advertisement

GI & Endoscopy

Artificial intelligence is a growing area in gastroenterology. It's something NextServices President Praveen Suthrum predicted as an industry disruptor in his book, Scope Forward, and last year marked several advancements.

Advertisement

Iterative Scopes and Eli Lilly reached a partnership Feb. 11 to conduct research around how artificial intelligence can improve understanding of inflammatory bowel disease pathophysiology and target identification.

Providers have attempted to improve colorectal cancer screening rates by using risk stratification, but recent research debunked the effectiveness of the strategy, according to a study published in February issue of The American Journal of Gastroenterology.

Advertisement